-
- Ashley Meilleur
- Authors' Affiliations: Departments of 1Health Care Policy and 2Medicine, Harvard Medical School, Department of Society, Human Development, and Health, 3Harvard School of Public Health, 4Massachusetts General Hospital Cancer Center, Boston, Massachusetts; and 5Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute, 6Division of Epidemiology, College of Public Health, and 7Division of Cancer Control and Prevention, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio
-
- S.V. Subramanian
- Authors' Affiliations: Departments of 1Health Care Policy and 2Medicine, Harvard Medical School, Department of Society, Human Development, and Health, 3Harvard School of Public Health, 4Massachusetts General Hospital Cancer Center, Boston, Massachusetts; and 5Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute, 6Division of Epidemiology, College of Public Health, and 7Division of Cancer Control and Prevention, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio
-
- Jesse J. Plascak
- Authors' Affiliations: Departments of 1Health Care Policy and 2Medicine, Harvard Medical School, Department of Society, Human Development, and Health, 3Harvard School of Public Health, 4Massachusetts General Hospital Cancer Center, Boston, Massachusetts; and 5Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute, 6Division of Epidemiology, College of Public Health, and 7Division of Cancer Control and Prevention, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio
-
- James L. Fisher
- Authors' Affiliations: Departments of 1Health Care Policy and 2Medicine, Harvard Medical School, Department of Society, Human Development, and Health, 3Harvard School of Public Health, 4Massachusetts General Hospital Cancer Center, Boston, Massachusetts; and 5Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute, 6Division of Epidemiology, College of Public Health, and 7Division of Cancer Control and Prevention, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio
-
- Electra D. Paskett
- Authors' Affiliations: Departments of 1Health Care Policy and 2Medicine, Harvard Medical School, Department of Society, Human Development, and Health, 3Harvard School of Public Health, 4Massachusetts General Hospital Cancer Center, Boston, Massachusetts; and 5Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute, 6Division of Epidemiology, College of Public Health, and 7Division of Cancer Control and Prevention, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio
-
- Elizabeth B. Lamont
- Authors' Affiliations: Departments of 1Health Care Policy and 2Medicine, Harvard Medical School, Department of Society, Human Development, and Health, 3Harvard School of Public Health, 4Massachusetts General Hospital Cancer Center, Boston, Massachusetts; and 5Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute, 6Division of Epidemiology, College of Public Health, and 7Division of Cancer Control and Prevention, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio
書誌事項
- 公開日
- 2013-10-01
- DOI
-
- 10.1158/1055-9965.epi-13-0404
- 公開者
- American Association for Cancer Research (AACR)
この論文をさがす
説明
<jats:title>Abstract</jats:title><jats:p>“Neighborhoods and health” research has shown that area social factors are associated with the health outcomes that patients with cancer experience across the cancer control continuum. To date, most of this research has been focused on the attributes of urban areas that are associated with residents' poor cancer outcomes with less focused on attributes of rural areas that may be associated with the same. Perhaps because there is not yet a consensus in the United States regarding how to define “rural,” there is not yet an accepted analytic convention for studying issues of how patients' cancer outcomes may vary according to “rural” as a contextual attribute. The research that exists reports disparate findings and generally treats rural residence as a patient attribute rather than a contextual factor, making it difficult to understand what factors (e.g., unmeasured individual poverty, area social deprivation, area health care scarcity) may be mediating the poor outcomes associated with rural (or non-rural) residence. Here, we review literature regarding the potential importance of rural residence on cancer patients' outcomes in the United States with an eye towards identifying research conventions (i.e., spatial and analytic) that may be useful for future research in this important area. Cancer Epidemiol Biomarkers Prev; 22(10); 1657–67. ©2013 AACR.</jats:p>
収録刊行物
-
- Cancer Epidemiology, Biomarkers & Prevention
-
Cancer Epidemiology, Biomarkers & Prevention 22 (10), 1657-1667, 2013-10-01
American Association for Cancer Research (AACR)

